The global pharma industry experienced a 20% drop in social media posts on Covid-19 in Q1 2023 compared with the previous quarter, with the highest share accounted for Pfizer, according to GlobalData’s analysis of social media posts. GlobalData’s COVID-19 Cross-Sector Impact – Thematic Research report helps understand how the effect of COVID-19 on pharmaceutical sector compares with 17 other key sectors, in terms of equity indices, M&A volumes, jobs index, and filings. Buy the report here.
Smarter leaders trust GlobalData
Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of innovation and artificial intelligence, according to GlobalData.
Of the 50 leading companies in the pharma industry, Pfizer had the most mentions of Covid-19 in Q1 2023. GlobalData identified 98,758 Covid-19-related posts in the industry's social media activity - 6% of all posts - and a decrease of 20% in Q1 2023 compared with Q4 2022.
To further understand GlobalData's analysis on COVID-19 Cross-Sector Impact - Thematic Research buy the report here.
See Also:
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Social Media Analytics uses machine learning to uncover key insights and track sentiment across millions of social media posts across selected Twitter influencers and Reddit channels.
